Spontaneous activation of RNA-sensing pathways in autoimmune disease

Current Opinion in Immunology

Volumn 25, Issue 6, 2013, Pages 712-719

  Crampton, Steve P ^a   Bolland, Silvia ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; LIGAND; NUCLEIC ACID; RIBONUCLEASE; RNA; RNA ANTIBODY; TOLL LIKE RECEPTOR;

AUTOIMMUNE DISEASE; CYTOKINE RELEASE; ENDOCYTOSIS; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PATHOGENICITY; REVIEW; VIRUS INFECTION;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; IMMUNITY, INNATE; LIGANDS; NUCLEIC ACIDS; RNA; SIGNAL TRANSDUCTION;

EID: 84889092194     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.09.011     Document Type: Review

References (67)

1. Theofilopoulos A.N., Kono D.H., Beutler B., Baccala R. Intracellular nucleic acid sensors and autoimmunity. J Interferon Cytokine Res 2011, 31:867-886.
2. Wilkins C., Gale M. Recognition of viruses by cytoplasmic sensors. Curr Opin Immunol 2010, 22:41-47.
3. Kawai T., Akira S. Innate immune recognition of viral infection. Nat Immunol 2006, 7:131-137.
4. Honda K., Ohba Y., Yanai H., Negishi H., Mizutani T., Takaoka A., Taya C., Taniguchi T. Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction. Nature 2005, 434:1035-1040.
5. Sasai M., Linehan M.M., Iwasaki A. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 2010, 329:1530-1534.
6. Iwasaki A., Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995.
7. Avalos A.M., Busconi L., Marshak-Rothstein A. Regulation of autoreactive B cell responses to endogenous TLR ligands. Autoimmunity 2010, 43:76-83.
8. Takeuchi O., Akira S. MDA5/RIG-I and virus recognition. Curr Opin Immunol 2008, 20:17-22.
9. Stetson D.B. Endogenous retroelements and autoimmune disease. Curr Opin Immunol 2012, 24:692-697.
10. Crow M.K., Kirou K.A. Interferon-alpha in systemic lupus erythematosus. Curr Opin Rheumatol 2004, 16:541-547.
11. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., Flavell R.A., Bolland S. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 2007, 27:801-810.
12. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
13. Christensen S.R., Shupe J., Nickerson K., Kashgarian M., Flavell R.A., Shlomchik M.J. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 2006, 25:417-428.
14. Lee P.Y., Kumagai Y., Li Y., Takeuchi O., Yoshida H., Weinstein J., Kellner E.S., Nacionales D., Barker T., Kelly-Scumpia K., et al. TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med 2008, 205:2995-3006.
15. Savarese E., Steinberg C., Pawar R.D., Reindl W., Akira S., Anders H.J., Krug A. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis. Arthritis Rheum 2008, 58:1107-1115.
16. Pagni P.P., Traub S., Demaria O., Chasson L., Alexopoulou L. Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis. Autoimmunity 2010, 43:275-287.
17. Mouchess M.L., Arpaia N., Souza G., Barbalat R., Ewald S.E., Lau L., Barton G.M. Transmembrane mutations in Toll-like receptor 9 bypass the requirement for ectodomain proteolysis and induce fatal inflammation. Immunity 2011, 35:721-732.
18. Yu P., Musette P., Peng S.L. Toll-like receptor 9 in murine lupus: more friend than foe!. Immunobiology 2008, 213:151-157.
19. Demaria O., Pagni P.P., Traub S., de Gassart A., Branzk N., Murphy A.J., Valenzuela D.M., Yancopoulos G.D., Flavell R.A., Alexopoulou L. TLR8 deficiency leads to autoimmunity in mice. J Clin Invest 2010, 120:3651-3662.
20. Kawasaki A., Furukawa H., Kondo Y., Ito S., Hayashi T., Kusaoi M., Matsumoto I., Tohma S., Takasaki Y., Hashimoto H., et al. TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther 2011, 13:R41.
21. Shen N., Fu Q., Deng Y., Qian X., Zhao J., Kaufman K.M., Wu Y.L., Yu C.Y., Tang Y., Chen J.Y., et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A 2010, 107:15838-15843.
22. Moser K.L., Kelly J.A., Lessard C.J., Harley J.B. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun 2009, 10:373-379.
23. Jacob C.O., Zhu J., Armstrong D.L., Yan M., Han J., Zhou X.J., Thomas J.A., Reiff A., Myones B.L., Ojwang J.O., et al. Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus. Proc Natl Acad Sci U S A 2009, 106:6256-6261.
24. Salloum R., Niewold T.B. Interferon regulatory factors in human lupus pathogenesis. Transl Res 2011, 157:326-331.
25. Richez C., Yasuda K., Bonegio R.G., Watkins A.A., Aprahamian T., Busto P., Richards R.J., Liu C.L., Cheung R., Utz P.J., et al. IFN regulatory factor 5 is required for disease development in the FcgammaRIIB-/-Yaa and FcgammaRIIB-/- mouse models of systemic lupus erythematosus. J Immunol 2010, 184:796-806.
26. Han J.W., Zheng H.F., Cui Y., Sun L.D., Ye D.Q., Hu Z., Xu J.H., Cai Z.M., Huang W., Zhao G.P., et al. Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 2009, 41:1234-1237.
27. Lee J., Tattoli I., Wojtal K.A., Vavricka S.R., Philpott D.J. Girardin SE: pH-dependent internalization of muramyl peptides from early endosomes enables Nod1 and Nod2 signaling. J Biol Chem 2009, 284:23818-23829.
28. Sasawatari S., Okamura T., Kasumi E., Tanaka-Furuyama K., Yanobu-Takanashi R., Shirasawa S., Kato N., Toyama-Sorimachi N. The solute carrier family 15A4 regulates TLR9 and NOD1 functions in the innate immune system and promotes colitis in mice. Gastroenterology 2011, 140:1513-1525.
29. Wang Y., Shaked I., Stanford S.M., Zhou W., Curtsinger J.M., Mikulski Z., Shaheen Z.R., Cheng G., Sawatzke K., Campbell A.M., et al. The autoimmunity-associated gene PTPN22 potentiates Toll-like receptor-driven, Type 1 interferon-dependent immunity. Immunity 2013, 39:111-122.
30. Gregersen P.K., Lee H.S., Batliwalla F., Begovich A.B. PTPN22: setting thresholds for autoimmunity. Semin Immunol 2006, 18:214-223.
31. Chistiakov D.A. Interferon induced with helicase C domain 1 (IFIH1) and virus-induced autoimmunity: a review. Viral Immunol 2010, 23:3-15.
32. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., Ortmann W., Kosoy R., Ferreira R.C., Nordmark G., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
33. Crampton S.P., Deane J.A., Feigenbaum L., Bolland S. Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 2012, 188:1451-1459.
34. Crow Y.J., Hayward B.E., Parmar R., Robins P., Leitch A., Ali M., Black D.N., van Bokhoven H., Brunner H.G., Hamel B.C., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nat Genet 2006, 38:917-920.
35. Crow Y.J., Leitch A., Hayward B.E., Garner A., Parmar R., Griffith E., Ali M., Semple C., Aicardi J., Babul-Hirji R., et al. Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection. Nat Genet 2006, 38:910-916.
36. Rice G., Newman W.G., Dean J., Patrick T., Parmar R., Flintoff K., Robins P., Harvey S., Hollis T., O'Hara A., et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 2007, 80:811-815.
37. Gall A., Treuting P., Elkon K.B., Loo Y.M., Gale M., Barber G.N., Stetson D.B. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 2012, 36:120-131.
38. Stetson D.B., Ko J.S., Heidmann T., Medzhitov R. Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 2008, 134:587-598.
39. Scheid J.F., Mouquet H., Feldhahn N., Seaman M.S., Velinzon K., Pietzsch J., Ott R.G., Anthony R.M., Zebroski H., Hurley A., et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals. Nature 2009, 458:636-640.
40. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 2006, 6:823-835.
41. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 2002, 416:603-607.
42. Chaturvedi A., Pierce S.K. How location governs toll-like receptor signaling. Traffic 2009, 10:621-628.
43. Boule M.W., Broughton C., Mackay F., Akira S., Marshak-Rothstein A., Rifkin I.R. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 2004, 199:1631-1640.
44. Nickerson K.M., Christensen S.R., Shupe J., Kashgarian M., Kim D., Elkon K., Shlomchik M.J. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 2010, 184:1840-1848.
45. Wu X., Peng S.L. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum 2006, 54:336-342.
46. Ewald S.E., Barton G.M. Nucleic acid sensing Toll-like receptors in autoimmunity. Curr Opin Immunol 2011, 23:3-9.
47. Brinkmann M.M., Spooner E., Hoebe K., Beutler B., Ploegh H.L., Kim Y.M. The interaction between the ER membrane protein UNC93B and TLR3, 7, and 9 is crucial for TLR signaling. J Cell Biol 2007, 177:265-275.
48. Kim Y.M., Brinkmann M.M., Paquet M.E., Ploegh H.L. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 2008, 452:234-238.
49. Fukui R., Saitoh S., Matsumoto F., Kozuka-Hata H., Oyama M., Tabeta K., Beutler B., Miyake K. Unc93B1 biases Toll-like receptor responses to nucleic acid in dendritic cells toward DNA- but against RNA-sensing. J Exp Med 2009, 206:1339-1350.
50. Fukui R., Saitoh S., Kanno A., Onji M., Shibata T., Ito A., Onji M., Matsumoto M., Akira S., Yoshida N., et al. Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity 2011, 35:69-81.
51. Lee B.L., Moon J.E., Shu J.H., Yuan L., Newman Z.R., Schekman R., Barton G.M. UNC93B1 mediates differential trafficking of endosomal TLRs. Elife 2013, 2:e00291.
52. Ito T., Amakawa R., Kaisho T., Hemmi H., Tajima K., Uehira K., Ozaki Y., Tomizawa H., Akira S., Fukuhara S. Interferon-alpha and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J Exp Med 2002, 195:1507-1512.
53. Walsh E.R., Pisitkun P., Voynova E., Deane J.A., Scott B.L., Caspi R.R., Bolland S. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proc Natl Acad Sci U S A 2012, 109:16276-16281.
54. Sun X., Wiedeman A., Agrawal N., Teal T.H., Tanaka L., Hudkins K.L., Alpers C.E., Bolland S., Buechler M.B., Hamerman J.A., et al. Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice. J Immunol 2013, 190:2536-2543.
55. Baumann I., Kolowos W., Voll R.E., Manger B., Gaipl U., Neuhuber W.L., Kirchner T., Kalden J.R., Herrmann M. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 2002, 46:191-201.
56. Savarese E., Chae O.W., Trowitzsch S., Weber G., Kastner B., Akira S., Wagner H., Schmid R.M., Bauer S., Krug A. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 2006, 107:3229-3234.
57. Tluk S., Jurk M., Forsbach A., Weeratna R., Samulowitz U., Krieg A.M., Bauer S., Vollmer J. Sequences derived from self-RNA containing certain natural modifications act as suppressors of RNA-mediated inflammatory immune responses. Int Immunol 2009, 21:607-619.
58. Green N.M., Moody K.S., Debatis M., Marshak-Rothstein A. Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. J Biol Chem 2012, 287:39789-39799.
59. Lau C.M., Broughton C., Tabor A.S., Akira S., Flavell R.A., Mamula M.J., Christensen S.R., Shlomchik M.J., Viglianti G.A., Rifkin I.R., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 2005, 202:1171-1177.
60. Yu P., Lübben W., Slomka H., Gebler J., Konert M., Cai C., Neubrandt L., Prazeres da Costa O., Paul S., Dehnert S., et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 2012, 37:867-879.
61. Lehmann S.M., Kruger C., Park B., Derkow K., Rosenberger K., Baumgart J., Trimbuch T., Eom G., Hinz M., Kaul D., et al. An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 2012, 15:827-835.
62. Maverakis E., Miyamura Y., Bowen M.P., Correa G., Ono Y., Goodarzi H. Light, including ultraviolet. J Autoimmun 2010, 34:J247-J257.
63. Malathi K., Dong B., Gale M., Silverman R.H. Small self-RNA generated by RNase L amplifies antiviral innate immunity. Nature 2007, 448:816-819.
64. Kieseier B.C. The mechanism of action of interferon-beta in relapsing multiple sclerosis. CNS Drugs 2011, 25:491-502.
65. Platanias L.C., Uddin S., Colamonici O.R. Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. J Biol Chem 1994, 269:17761-17764.
66. de Weerd N.A., Vivian J.P., Nguyen T.K., Mangan N.E., Gould J.A., Braniff S.J., Zaker-Tabrizi L., Fung K.Y., Forster S.C., Beddoe T., et al. Structural basis of a unique interferon-beta signaling axis mediated via the receptor IFNAR1. Nat Immunol 2013, 14(9):901-907.
67. Guiducci C., Gong M., Alma-Martina C., Zhaohui X., Tripodo C., Bennett L., Crain C., Quartier P., Cush J.J., Pascual V., Coffman R.L., Barrat F.J. RNA recognition by human TLR8 can lead to autoimmune inflammation. J Exp Med 2014, (in press).